| Anne Elizabeth Miller, MD | |
|
1300 E 20th St, Cheyenne, WY 82001-4021 | |
| (307) 634-2020 | |
| (307) 635-6510 |
| Full Name | Anne Elizabeth Miller |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 28 Years |
| Location | 1300 E 20th St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255334637 | NPI | - | NPPES |
| 116087700 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 6531A (Wyoming) | Secondary |
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 6531A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheyenne Regional Medical Center | Cheyenne, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheyenne Eye Clinic, Llc | 3072865815 | 5 |
News Archive
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
South Dakota State University research is exploring a "fusion strategy" for making improved vaccines to protect pigs and humans against some strains of E. coli.
A simple and inexpensive screening test can show which diabetic patients face an increased risk of heart disease, which can help them get the care they need, faster — and proactively reduce their risk of heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct, a research team at the Nanyang Technological University, Singapore (NTU Singapore) has found.
› Verified 3 days ago
| Entity Name | Cheyenne Eye Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720054802 PECOS PAC ID: 2264414846 Enrollment ID: O20040607000953 |
News Archive
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
South Dakota State University research is exploring a "fusion strategy" for making improved vaccines to protect pigs and humans against some strains of E. coli.
A simple and inexpensive screening test can show which diabetic patients face an increased risk of heart disease, which can help them get the care they need, faster — and proactively reduce their risk of heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct, a research team at the Nanyang Technological University, Singapore (NTU Singapore) has found.
› Verified 3 days ago
| Entity Name | Cheyenne Eye Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720054802 PECOS PAC ID: 3072865815 Enrollment ID: O20181009003824 |
News Archive
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
South Dakota State University research is exploring a "fusion strategy" for making improved vaccines to protect pigs and humans against some strains of E. coli.
A simple and inexpensive screening test can show which diabetic patients face an increased risk of heart disease, which can help them get the care they need, faster — and proactively reduce their risk of heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct, a research team at the Nanyang Technological University, Singapore (NTU Singapore) has found.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne Elizabeth Miller, MD 1300 E 20th St, Cheyenne, WY 82001-4021 Ph: (307) 634-2020 | Anne Elizabeth Miller, MD 1300 E 20th St, Cheyenne, WY 82001-4021 Ph: (307) 634-2020 |
News Archive
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
South Dakota State University research is exploring a "fusion strategy" for making improved vaccines to protect pigs and humans against some strains of E. coli.
A simple and inexpensive screening test can show which diabetic patients face an increased risk of heart disease, which can help them get the care they need, faster — and proactively reduce their risk of heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct, a research team at the Nanyang Technological University, Singapore (NTU Singapore) has found.
› Verified 3 days ago
Shauna K Mckusker, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1300 E 20th St, Cheyenne, WY 82001 Phone: 307-634-2020 Fax: 307-635-6510 | |
Dr. Patricia Durkin Stepp, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 Fax: 307-778-7551 | |
Dr. Randolph Leigh Johnston, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1300 E 20th St, Cheyenne, WY 82001 Phone: 307-634-2020 Fax: 307-635-6510 | |
Dr. William Charles Stewart, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 109 E 17th St, Suite 3407, Cheyenne, WY 82001 Phone: 843-606-0776 Fax: 888-808-9564 |